
    
      Objective:

      To evaluate the clinical outcomes of Neurokinin 1 Receptor antagonist in Covid-19 patients
      against the usual treatments as controls

      Dosage Aprepitant capsules may be given to patients from 3-5 days fosaprepitant dimeglumine
      (Injection 115mg, prodrug form of aprepitant) may be substituted for oral drug in case of
      critical patients May be taken with or without food

      Administration One capsule of Aprepitant once a day for 3-5 days
    
  